Shaping the future of endoscopy-enabled care through innovation and operational excellence...
Data from over 1 million Tablo treatments among the findings presented at the American Society of Nephrology’s Kidney Week 2025...
Successful completion of the first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval...
Apollo Cradle & Children’ Hospital along with Apollo Fertility launches the 3rd National Cradle Conference 2025, highlighting breakthrough technologies and best practices in fertility, maternal and child health...
Helping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower Costs, and Globally Accepted Data...
The forum discusses strategies to strengthen vaccine production capacity, accelerate technology transfer, and expand access to safe, high-quality, and affordable vaccines for all...
The 52-week data from these two Phase III clinical trials demonstrate the durability of response and highlight the comprehensive long-term clinical benefits of HTD1801 in patients with T2DM...
This collaboration marks Everest’s strategic expansion into ophthalmology, a high-potential “blue-ocean” therapeutic area...
Renowned pain management and medical technology leader to accelerate Glucotrack’s strategy for integrated glucose monitoring applications, building on the Company’s 2024 expansion into epidural monitoring ...
The urgent need for health insurance as an out-of-pocket expenditure, is frequently unaffordable for many families...
